Evolus celebrates Irish launch of new ESTYME® HA range

Performance beauty company Evolus welcomed practitioners and clinic professionals from across Ireland to the launch of its new hyaluronic acid (HA) filler collection, Estyme.

The event took place at Dublin’s Light House Cinema on June 8 and was organised by Marketing Manager Dallas Waltham and Irish National Sales Manager Elaine O’Reilly.

Estyme is Evolus’ new range of injectable HA gels. They were designed to modify skin anatomy and enhance facial appearance using a proprietary technology called COLD-X TECHNOLOGY by Symatese.

The range comprises four products: Estyme Sculpt, Estyme Lips, Estyme Form and, Estyme Smooth.

Delegates heard from members of Evolus’ international faculty, who shared their clinical experience using the products and discussed the importance of facial anatomy knowledge when administering HA fillers.

Speakers included consultant plastic surgeon Miss Natasha Berridge, nurse prescriber Amy Bird and Dr Jennifer Owens.

During her presentation, Amy Bird showcased a variety of case studies featuring products from across the Estyme portfolio, including Estyme Smooth and Estyme Lips. She highlighted the importance of understanding a patient’s tissue characteristics and ability to support the product in order to achieve optimal outcomes.

Amy also discussed the integration of Estyme into clinical practice, citing benefits such as natural-looking results and reduced swelling. She emphasised the importance of understanding product characteristics alongside clinical expertise to achieve consistent results.

Dr Jennifer Owens shared her experience using the wider Evolus portfolio and presented a case study involving a patient treated for volume loss associated with GLP-1 medication use.

Throughout the event, speakers highlighted their positive experiences with the Estyme range, noting its natural-looking outcomes, tissue integration and long-lasting results.

Evolus has also announced a series of VIP training events scheduled to take place in Dublin and Cork over the coming months for medical practitioners interested in learning more about the new injectable HA gel range.